Stella is a 27-year-old transgender woman with a past medical history of HIV treated with bictegravir/emtricitabine/tenofovir alafenamide (BIC/FTC/TAF). Her most recent CD4 count was in the normal range, and her HIV viral load was undetectable three months ago. She takes estrogen supplements and testosterone blockers but has not had gender-affirming surgeries of any kind. She presents to your clinic for a follow-up visit. She reports three new sexual partners in the past 90 days (including oral and receptive anal sex) but none in the past 30 days. She denies any current symptoms. Her anal, oral, and urine nucleic acid amplification tests (NAATs) return positive for C. trachomatis. What treatment do you recommend?